These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37919758)

  • 1. Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA
    Crit Care; 2023 Nov; 27(1):421. PubMed ID: 37919758
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA; Song T; Durham L; Garrison L; Smith D; Molnar Z; Scheier J; Deliargyris EN; Moazami N
    Crit Care; 2023 Jun; 27(1):243. PubMed ID: 37337243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry.
    Supady A; Staudacher DL; Wengenmayer T
    Crit Care; 2023 Jul; 27(1):297. PubMed ID: 37488613
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation.
    Lewis TC; Merchan C; Toy B; Goldenberg RM; Geraci TC; Chang SH; Galloway AC; Smith DE; Moazami N
    ASAIO J; 2021 Aug; 67(8):856-861. PubMed ID: 34339400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution.
    Putzu A; Schorer R
    J Crit Care; 2021 Oct; 65():140-141. PubMed ID: 34148009
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement.
    Putzu A; Schorer R
    J Crit Care; 2021 Dec; 66():189-190. PubMed ID: 34334278
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study.
    Akil A; Ziegeler S; Rehers S; Ernst EC; Fischer S
    Int J Artif Organs; 2022 Jul; 45(7):615-622. PubMed ID: 35695200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement.
    Köhler T; Schwier E; Henzler D; Eickmeyer C
    J Crit Care; 2021 Dec; 66():187-188. PubMed ID: 34330558
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of Patients Treated With Extracorporeal Hemoadsorption and Extracorporeal Membrane Oxygenation: Results From a Nation-Wide Registry.
    Heidenreich A; Kaier K; Bode C; Zehender M; von Zur Mühlen C; Duerschmied D; Wengenmayer T; Stachon P; Supady A
    ASAIO J; 2023 Mar; 69(3):339-343. PubMed ID: 35857288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response.
    Supady A; Duerschmied D
    J Crit Care; 2021 Dec; 66():31-32. PubMed ID: 34418636
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemoadsorption treatment with CytoSorb
    Träger K; Skrabal C; Fischer G; Schroeder J; Marenski L; Liebold A; Reinelt H; Datzmann T
    Int J Artif Organs; 2020 Jun; 43(6):422-429. PubMed ID: 31868089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of extracorporeal therapies in critically ill COVID-19 patients.
    Zhou Z; Kuang H; Ma Y; Zhang L
    J Zhejiang Univ Sci B; 2021 Sept 15; 22(9):701-717. PubMed ID: 34514751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients.
    Peng JY; Li L; Zhao X; Ding F; Hou X; Peng Z
    Blood Purif; 2022; 51(5):410-416. PubMed ID: 34407530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of acute neurological complications and pathological neuroimaging findings in critically ill COVID-19 patients with and without VV-ECMO treatment.
    Ippolito A; Urban H; Ghoroghi K; Rosbach N; Lingwal N; Adam EH; Friedrichson B; Steinbicker AU; Hattingen E; Wenger KJ
    Sci Rep; 2022 Oct; 12(1):17423. PubMed ID: 36261436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.
    Ronco C; Bagshaw SM; Bellomo R; Clark WR; Husain-Syed F; Kellum JA; Ricci Z; Rimmelé T; Reis T; Ostermann M
    Blood Purif; 2021; 50(1):17-27. PubMed ID: 32454500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry.
    Song T; Hayanga J; Durham L; Garrison L; McCarthy P; Barksdale A; Smith D; Bartlett R; Jaros M; Nelson P; Molnar Z; Deliargyris E; Moazami N
    Front Med (Lausanne); 2021; 8():773461. PubMed ID: 34988092
    [No Abstract]   [Full Text] [Related]  

  • 17. Post VV-ECMO Weaning Hyperinflammation-Can Prophylactic Hemoadsorption Treatment Prevent Complications?
    Kovacevic P; Dragic S; Jandric M; Momcicevic D; Topolovac S; Malesevic V; Kovacevic T; Matejic-Spasic M; Knezevic T; Zlojutro B
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO.
    Napp LC; Lebreton G; De Somer F; Supady A; Pappalardo F
    Artif Organs; 2021 Oct; 45(10):1240-1249. PubMed ID: 34152637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons Learned from Extracorporeal Membrane Oxygenation Use During the COVID-19 Pandemic.
    Essig R; Sundland R; Chokshi N
    Pediatr Ann; 2022 Jul; 51(7):e281-e285. PubMed ID: 35858215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoadsorption in isolated conjugated hyperbilirubinemia after extracorporeal membrane oxygenation support. Cholestasis of sepsis: A case report and review of the literature on differential causes of jaundice in ICU patient.
    Piwowarczyk P; Kutnik P; Potręć-Studzińska B; Sysiak-Sławecka J; Rypulak E; Borys M; Czczuwar M
    Int J Artif Organs; 2019 May; 42(5):263-268. PubMed ID: 30919732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.